# Lentigo

> Mediated Wiki article. Canonical URL: https://mediated.wiki/source/Lentigo
> Markdown URL: https://mediated.wiki/source/Lentigo.md
> Source: https://en.wikipedia.org/wiki/Lentigo
> Source revision: 1323183912
> License: Creative Commons Attribution-ShareAlike 4.0 International (https://creativecommons.org/licenses/by-sa/4.0/)

{{Short description|Small pigment spots on skin}}
{{for|the conch genus|Lentigo (gastropod)}}

{{Infobox medical condition (new)
| name            = Lentigo
| synonyms        =
| image           = Female skin large.jpg
| caption         = A mild form of ''lentigo simplex''
| pronounce       =
| field           =
| symptoms        =
| complications   =
| onset           =
| duration        =
| types           =
| causes          =
| risks           =
| diagnosis       =
| differential    =
| prevention      =
| treatment       =
| medication      =
| prognosis       =
| frequency       =
| deaths          =
}}
A '''lentigo''' ({{IPAc-en|l|ɛ|n|ˈ|t|aɪ|g|oʊ}}; plural '''lentigines''', {{IPAc-en|l|ɛ|n|ˈ|t|ɪ|dʒ|ᵻ|n|iː|z}}) is a small pigmented spot on the skin with a clearly defined edge, surrounded by normal-appearing skin. It is a harmless (benign) [hyperplasia](/source/hyperplasia) of [melanocytes](/source/melanocytes) which is linear in its spread. This means the hyperplasia of melanocytes is restricted to the cell layer directly above the [basement membrane](/source/basement_membrane) of the [epidermis](/source/epidermis_(skin)) where melanocytes normally reside. This is in contrast to the "nests" of multi-layer melanocytes found in [moles](/source/Melanocytic_nevus) (melanocytic [nevi](/source/nevi)). Because of this characteristic feature, the adjective ''lentiginous'' is used to describe other skin lesions that similarly proliferate linearly within the basal cell layer.<ref name="randomHouse">''Random House Webster's Unabridged Dictionary.'' Random House, Inc. 2001. p. 1101. {{ISBN|0-375-72026-X}}.</ref><ref name="Robbins and Cotran">''Robbins and Cotran Pathologic Basis of Disease'' Elsevier. 2005. p. 1232. {{ISBN|0-8089-2302-1}}.</ref>

==Diagnosis==

Conditions characterized by lentigines include:<ref name="Andrews">{{cite book |author1=William D. James |author2=Timothy G. Berger |title=Andrews' Diseases of the Skin: Clinical Dermatology |publisher=Saunders Elsevier |year=2006 |pages=686–87 |isbn=0-7216-2921-0 |display-authors=etal}}</ref>
* [Lentigo simplex](/source/Lentigo_simplex)
* [Solar lentigo](/source/Solar_lentigo) (Liver spots)
* [PUVA lentigines](/source/PUVA_lentigines)
* [Ink spot lentigo](/source/Ink_spot_lentigo)
* [LEOPARD syndrome](/source/LEOPARD_syndrome)
* [Mucosal lentigines](/source/Mucosal_lentigines)
* [Multiple lentigines syndrome](/source/Multiple_lentigines_syndrome)
* [Moynahan syndrome](/source/Moynahan_syndrome)
* [Generalized lentiginosis](/source/Generalized_lentiginosis)
* [Centrofacial lentiginosis](/source/Centrofacial_lentiginosis)
* [Carney complex](/source/Carney_complex)
* [Inherited patterned lentiginosis in black persons](/source/Inherited_patterned_lentiginosis_in_black_persons)
* [Partial unilateral lentiginosis](/source/Partial_unilateral_lentiginosis)
* [Peutz–Jeghers syndrome](/source/Peutz%E2%80%93Jeghers_syndrome)
* [Lentigo maligna](/source/Lentigo_maligna)
* [Lentigo maligna melanoma](/source/Lentigo_maligna_melanoma)
* [Acral lentiginous melanoma](/source/Acral_lentiginous_melanoma)

===Differential diagnosis===
Lentigines are distinguished from [freckles](/source/freckles) (ephelis) based on the proliferation of melanocytes. Freckles have a relatively normal number of melanocytes but an increased ''amount'' of [melanin](/source/melanin). A lentigo has an increased ''number'' of melanocytes. Freckles will increase in number and darkness with sunlight exposure, whereas lentigines will stay stable in their color regardless of sunlight exposure.<ref name="Robbins and Cotran"/>

==Treatment==
Lentigines by themselves are benign,<ref name=":0">{{Cite web|url=http://www.dermnetnz.org/topics/lentigo-simplex/|title=Lentigo simplex {{!}} DermNet New Zealand|website=www.dermnetnz.org|language=en|access-date=2017-02-12}}</ref> however one might desire the removal or treatment of some of them for cosmetic purposes. In this case they can be removed surgically,<ref name=":0" /><ref>{{Cite journal|last=Juhász|first=Margit L. W.|last2=Marmur|first2=Ellen S.|date=2015-01-01|title=Reviewing Challenges in the Diagnosis and Treatment of Lentigo Maligna and Lentigo-Maligna Melanoma|journal=Rare Cancers and Therapy|volume=3|pages=133–45|doi=10.1007/s40487-015-0012-9|issn=2195-6014|pmc=4837936|pmid=27182482}}</ref> or lightened with the use of topical depigmentation agents. Some common depigmentation agents such as azelaic acid and kojic acid seem to be inefficient in this case,<ref>{{Cite journal|last=Hermanns|first=J. F.|last2=Petit|first2=L.|last3=Piérard-Franchimont|first3=C.|last4=Paquet|first4=P.|last5=Piérard|first5=G. E.|date=2002-01-01|title=Assessment of topical hypopigmenting agents on solar lentigines of Asian women|journal=Dermatology|volume=204|issue=4|pages=281–86|doi=10.1159/000063359|issn=1018-8665|pmid=12077522}}</ref> however other agents might work well (4% hydroquinone,<ref>{{Cite journal|last=Cook-Bolden|first=Fran E.|last2=Hamilton|first2=Saonjie F.|date=2008-04-01|title=An open-label study of the efficacy and tolerability of microencapsulated hydroquinone 4% and retinol 0.15% with antioxidants for the treatment of hyperpigmentation|journal=Cutis|volume=81|issue=4|pages=365–71|issn=0011-4162|pmid=18491487}}</ref> 5% topical cysteamine,<ref>{{Cite journal|last=Mansouri|first=P.|last2=Farshi|first2=S.|last3=Hashemi|first3=Z.|last4=Kasraee|first4=B.|date=2015-07-01|title=Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial|journal=The British Journal of Dermatology|volume=173|issue=1|pages=209–17|doi=10.1111/bjd.13424|issn=1365-2133|pmid=25251767}}</ref> 10% topical ascorbic acid<ref>{{Cite journal|last=Khemis|first=Abdallah|last2=Cabou|first2=Jérôme|last3=Dubois|first3=Jacques|last4=Ortonne|first4=Jean-Paul|date=2011-12-01|title=A randomized controlled study to evaluate the depigmenting activity of L-ascorbic acid plus phytic acid-serum vs. placebo on solar lentigines|journal=Journal of Cosmetic Dermatology|volume=10|issue=4|pages=266–72|doi=10.1111/j.1473-2165.2011.00588.x|issn=1473-2165|pmid=22151934}}</ref>).

== See also ==
* [Freckle](/source/Freckle)
* [List of skin diseases](/source/List_of_skin_diseases)
* [Mole](/source/Nevus)
* [Skin disease](/source/Skin_disease)
* [Skin lesion](/source/Skin_lesion)

== References ==
{{Reflist}}
== External links ==
{{Medical resources
| DiseasesDB      = 34325
| ICD10           = {{ICD10|L|81|4|l|80}}
| ICD9            = {{ICD9|709.09}}
| ICDO            =
| OMIM            =
| MedlinePlus     =
| eMedicineSubj   = derm
| eMedicineTopic  = 221
| MeshID          = D007911
| SNOMED CT       = 398744007
}}
{{wiktionary}}
{{Clinical and histological nomenclature for skin lesions}}
{{Pigmentation disorders}}
{{Skin tumors, nevi and melanomas}}

Category:Melanocytic nevi and neoplasms
Category:Disturbances of human pigmentation

---
Adapted from the Wikipedia article [Lentigo](https://en.wikipedia.org/wiki/Lentigo) by Wikipedia contributors ([contributor history](https://en.wikipedia.org/wiki/Lentigo?action=history)). Available under [Creative Commons Attribution-ShareAlike 4.0 International](https://creativecommons.org/licenses/by-sa/4.0/). Changes may have been made.
